TruSeq ChIP-Seq

TruSeq ChIP-Seq

Chromatin immunoprecipitation (ChIP) sequencing leverages next-generation sequencing (NGS) to quickly and efficiently determine the distribution and abundance of DNA-bound targets of interest across the genome. Illumina TruSeq ChIP Sample Preparation Kits require 5–10 ng of DNA and provides 24 indices.

Catalog ID(s):
IP-202-1012 (48 rxns) (Set A: 12 indices)
IP-202-1024 (48 rxns) (Set B: 12 indices)
Order Now Support Training

Please rotate your device for details

* Library prep is compatible with all Illumina instruments. Recommended instruments chosen based on typical output and analysis need for selected application.
† Coverage based on 15M reads per sample for identification of transcription factor binding. Other applications require different coverage
Project Recommendations
Species Compatibility Compatible with any species
Recommended Illumina Instrument* NextSeq 500 HiSeq 2500 (Dual Flow Cell)
Recommended Samples per run 8–24 40–264
Run Mode Mid Output High Output Rapid Run High Output
Recommended Read Length 1x50 bp 1x50 bp 1x50 bp 1x50 bp
Recommended Secondary Analysis
  • FASTQ files with 3rd party analysis
Order Now Support Training
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.